Nautilus Biotechnology (NAUT) Assets Average (2020 - 2026)

Nautilus Biotechnology (NAUT) has 7 years of Assets Average data on file, last reported at $184.4 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 21.58% year-over-year to $184.4 million; the trailing twelve-month figure through Mar 2026 stood at $184.4 million (down 21.58% YoY), and the FY2025 full-year result was $216.9 million, down 20.87% from the prior year.
• Assets Average retreated to $184.4 million in Q1 2026, from $196.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $391.6 million in Q1 2022 to a low of $184.4 million in Q1 2026.
• A 5-year average of $291.2 million and a median of $297.1 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average surged 232.52% in 2022 and slipped 22.23% in 2025, its largest moves.
• Tracing NAUT's Assets Average over 5 years: stood at $354.7 million in 2022, then declined by 12.05% to $312.0 million in 2023, then declined by 19.47% to $251.2 million in 2024, then declined by 21.98% to $196.0 million in 2025, then fell by 5.9% to $184.4 million in 2026.
• Business Quant data shows NAUT's Assets Average at $184.4 million in Q1 2026, $196.0 million in Q4 2025, and $207.1 million in Q3 2025.